KIR2DL3 and cancer: (93) described in NSCLC an increased frequency of the KIR2DL1-C2 and KIR3DL1-Bw4(Thre80) combinations but decreased frequency of the KIR2DL3-C1/C1 combination, suggesting the protection of cancer cells by strong KIR-HLA interactions.